AMGN vs TMUS · P/E 24, rev $10.05B vs P/E 19, rev $22.79B
Amgen Inc (AMGN) versus T-Mobile US Inc (TMUS) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
T-Mobile US Inc (TMUS) is a telecom services company listed on NASDAQ. It is led by Mike Sievert.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported TMUS revenue for 2026-06-30 was $22.79B. Net income was $3.24B. Revenue was down 1.4% from 2026-03-31 to 2026-06-30. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
Not investment advice. Open the AMGN and TMUS stock pages for the full models.
Not investment advice.